1 January 2025 false No description of principal activity Taxfiler 2024.6 true 15299935 business:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15299935 2024-12-31 15299935 2025-01-01 2025-12-31 15299935 business:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 15299935 business:FilletedAccounts 2025-01-01 2025-12-31 15299935 2025-12-31 15299935 business:Director1 2025-01-01 2025-12-31 15299935 business:Director2 2025-01-01 2025-12-31 15299935 business:RegisteredOffice 2025-01-01 2025-12-31 15299935 2024-12-31 15299935 core:WithinOneYear 2025-12-31 15299935 core:WithinOneYear 2024-12-31 15299935 core:ShareCapital core:PreviouslyStatedAmount 2025-12-31 15299935 core:ShareCapital core:PreviouslyStatedAmount 2024-12-31 15299935 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-12-31 15299935 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-12-31 15299935 core:PreviouslyStatedAmount 2025-12-31 15299935 core:PreviouslyStatedAmount 2024-12-31 15299935 business:SmallEntities 2025-01-01 2025-12-31 15299935 countries:EnglandWales 2025-01-01 2025-12-31 15299935 core:PlantMachinery 2025-01-01 2025-12-31 15299935 core:FurnitureFittings 2025-01-01 2025-12-31 15299935 core:PlantMachinery 2024-12-31 15299935 core:FurnitureFittings 2024-12-31 15299935 core:PlantMachinery 2025-12-31 15299935 core:FurnitureFittings 2025-12-31 15299935 2023-11-21 2024-12-31 iso4217:GBP xbrli:pure
Company Registration No. 15299935 (England and Wales)
Future Medicine Limited Unaudited accounts for the year ended 31 December 2025
Future Medicine Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Future Medicine Limited Company Information for the year ended 31 December 2025
Directors
James Jean-Pierre Drake Danny Alexander Al-Khafaji
Company Number
15299935 (England and Wales)
Registered Office
Future Medicine Ltd 1 Albert Place London London N3 1QB England
- 3 -
Future Medicine Limited Statement of financial position as at 31 December 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
1,545
2,318
Current assets
Debtors
5
188,867
62,004
Cash at bank and in hand
5,418
49,257
194,285
111,261
Creditors: amounts falling due within one year
6
(801,988)
(411,755)
Net current liabilities
(607,703)
(300,494)
Net liabilities
(606,158)
(298,176)
Capital and reserves
Called up share capital
100
100
Profit and loss account
(606,258)
(298,276)
Shareholders' funds
(606,158)
(298,176)
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 8 June 2026 and were signed on its behalf by
Danny Alexander Al-Khafaji Director Company Registration No. 15299935
- 4 -
Future Medicine Limited Notes to the Accounts for the year ended 31 December 2025
1
Statutory information
Future Medicine Limited is a private company, limited by shares, registered in England and Wales, registration number 15299935. The registered office is Future Medicine Ltd, 1 Albert Place, London, London, N3 1QB, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% Straight Line
Fixtures & fittings
25% Straight Line
Going concern
The accounts have been prepared on the going concern basis which assumes the continued support of Mr James Drake, who is a director of the company.
4
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 January 2025
1,608
1,483
3,091
At 31 December 2025
1,608
1,483
3,091
Depreciation
At 1 January 2025
402
371
773
Charge for the year
402
371
773
At 31 December 2025
804
742
1,546
Net book value
At 31 December 2025
804
741
1,545
At 31 December 2024
1,206
1,112
2,318
- 5 -
Future Medicine Limited Notes to the Accounts for the year ended 31 December 2025
5
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
6,172
6,272
Trade debtors
7,200
-
Amounts due from group undertakings etc.
164,245
44,482
Other debtors
11,250
11,250
188,867
62,004
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
20,731
25,470
Taxes and social security
5,123
3,948
Loans from directors
773,134
379,337
Accruals
3,000
3,000
801,988
411,755
7
Transactions with related parties
Creditors as at 31 December 2025 include an amount of £773,134 (2024: £379,337) payable to Mr James Drake who is a director of the company. Other debtors as at 31 December 2025 include amounts of £56,607 (2024: 35,205) from Of Lost Time Limited, £98,361 (2024: nil) from Art and Science UK Limited and £9,277 (2024: £9,277) from The Drake Foundation, which is not-for profit company, where Mr James Drake is a director of all three companies.
8
Average number of employees
During the year the average number of employees was 4 (2024: 3).
- 6 -